USPTO serial 79349582
EDIGENE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 21, 2023
- Examiner
- OSGOOD, KRYSTINA E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EDIGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Paulo A. de Almeida
Paulo A. de Almeida Patel & Almeida PC22543 Ventura Blvd., Ste. 220 #1200Woodland Hills, CA 91364UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for medical purposes for the treatment of gene mutation related diseases, hematological diseases and psychiatric and immune system related diseases and disorders; styptic preparations; medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, viral, metabolic, endocrine, musculoskeletal, oncological diseases, cardiovascular and cerebrovascular diseases, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; pharmaceutical preparations, namely, antivirals, pharmaceutical preparations for suppressing tumors, pharmaceutical preparations for the treatment of cancers; stem cells for medical purposes; surgical implants comprised of living tissues; blood for medical purposes; biological preparations for the treatment of cancer; pharmaceutical preparations for activating cellular function; cytostatics for medical purposes; living cells for medical use; ophthalmological preparations; pharmaceutical products for ophthalmological use; cord blood for medical purposes | ACTIVE | — |
| 042 | Biotechnology research; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; structural and functional analysis of genomes; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; analysis of the mode of action of chemical combinations on animals; technological research in the field of novel drug development; scientific laboratory services; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; medical research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 18, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 26, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 26, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 21, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 21, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 21, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 5, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 5, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 16, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 16, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 16, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 31, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 18, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 29, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 29, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 4, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 3, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 16, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 15, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |